+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
In-Vitro Diagnostics Quality Control Market by Product Type, Technology, Application, End User - Global Forecast 2026-2032- Product Image
In-Vitro Diagnostics Quality Control Market by Product Type, Technology, Application, End User - Global Forecast 2026-2032- Product Image
Sale

In-Vitro Diagnostics Quality Control Market by Product Type, Technology, Application, End User - Global Forecast 2026-2032

  • Report

  • 198 Pages
  • June 2026
  • Region: Global
  • 360iResearch™
  • ID: 4904896
UP TO OFF until Jan 01st 2027
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The In-Vitro Diagnostics Quality Control Market is projected to reach USD 1.74 Billion in 2026. It is expected to continue growing at a CAGR of 8.67%, reaching USD 2.88 Billion by 2032.

In-vitro diagnostics quality control is a mission-critical discipline that safeguards the accuracy, precision, reproducibility, and clinical reliability of laboratory testing. As hospitals, reference laboratories, public health networks, and point-of-care settings expand testing volumes, demand is rising for independent quality control materials, calibrators, proficiency testing, external quality assessment, laboratory information system integration, and standardized quality management practices.

The industry is shaped by internationally recognized requirements such as ISO 15189 for medical laboratories, CLIA requirements in the United States, accreditation practices, EU IVDR obligations, and regulator-led post-market surveillance. These frameworks reinforce the role of IVD quality control in reducing diagnostic error, supporting patient safety, maintaining traceability, and strengthening confidence in clinical decision-making across routine and specialized testing.

Transformative Shifts in the IVD Quality Control Landscape

The IVD quality control landscape is shifting from periodic, manual review toward continuous, risk-based, and digitally connected quality assurance. Laboratories are increasingly managing high-throughput immunoassay, clinical chemistry, hematology, microbiology, coagulation, urinalysis, and molecular diagnostics platforms, which require more sophisticated lot-to-lot verification, peer comparison, internal quality control, and instrument performance monitoring.

Regulatory modernization is also changing supplier and laboratory behavior. The EU IVDR has increased evidence requirements for IVD products, while FDA quality system expectations, global accreditation programs, and post-pandemic investments in diagnostic resilience have elevated demand for traceable, commutable, stable, and assay-relevant QC materials across centralized, near-patient, and decentralized testing environments.

Cumulative Impact of Artificial Intelligence on IVD Quality Control

Artificial intelligence is adding cumulative value across IVD quality control by improving anomaly detection, predictive maintenance, workflow triage, and statistical process monitoring. AI-enabled middleware can analyze Levey-Jennings trends, Westgard rule violations, peer group performance, reagent lot shifts, calibration bias, and instrument drift faster than manual review, helping laboratories intervene before quality failures affect patient results.

The strongest near-term impact is where AI supports, rather than replaces, validated quality management systems. Adoption depends on data integrity, explainability, cybersecurity, documented validation, auditability, and alignment with laboratory accreditation requirements. For QC material suppliers and diagnostic platform providers, AI creates opportunities to differentiate through connected controls, remote monitoring, automated exception management, and evidence-based decision support.

Key Regional Insights for IVD Quality Control

Asia-Pacific is expanding as China, India, Japan, South Korea, ASEAN countries, and Australia invest in healthcare infrastructure, infectious disease testing, oncology diagnostics, chronic disease management, and laboratory accreditation. China’s NMPA oversight, Japan’s PMDA pathway, India’s evolving CDSCO framework, South Korea’s MFDS regulation, and Australia’s NATA-accredited laboratory ecosystem are strengthening the need for reliable IVD quality control across routine and advanced diagnostics.

North America remains a mature, high-compliance region led by the United States and Canada, where CLIA, FDA quality system expectations, accreditation standards, and provincial laboratory requirements support sustained adoption of third-party controls, proficiency testing, and digital QC data management. Europe is being reshaped by IVDR implementation, ISO 15189-based laboratory competence, and stronger performance evidence expectations, while Latin America is led by Brazil and Mexico as laboratories modernize under ANVISA and COFEPRIS influence. The Middle East is advancing through GCC healthcare investment, national screening programs, and hospital accreditation, while Africa’s progress is tied to infectious disease programs, WHO-aligned laboratory quality systems, antimicrobial resistance surveillance, and expanded external quality assessment access.

Key Group Insights Across Global IVD Quality Control Markets

ASEAN markets are strengthening diagnostic quality through laboratory modernization, regional regulatory convergence, expanding universal health coverage initiatives, and growing access to molecular and point-of-care testing. The GCC is prioritizing high-quality hospital networks, national screening programs, medical tourism, and medical laboratory accreditation, creating demand for robust QC materials, proficiency testing, and digital quality systems.

The European Union is defined by IVDR implementation, notified body capacity, post-market performance follow-up, and evidence-based performance expectations, making quality control central to regulatory compliance and market access. BRICS countries combine scale with diverse regulatory maturity, creating opportunities for localized QC production, distributor education, and laboratory training. G7 markets lead in automation, accreditation, advanced diagnostics, and cybersecurity-aware data integration, while NATO countries increasingly view diagnostic readiness, supply security, and interoperable laboratory capacity as components of health system resilience.

Key Country Insights for IVD Quality Control

The United States leads through CLIA-regulated laboratories, FDA oversight, accreditation-driven quality systems, and strong use of third-party controls, proficiency testing, and peer comparison programs. Canada emphasizes provincial quality systems and accredited laboratory practice, while Mexico and Brazil are expanding diagnostic access under COFEPRIS and ANVISA oversight. In Europe, the United Kingdom, Germany, France, Italy, and Spain are advancing through ISO-aligned laboratory practices, national accreditation structures, and IVDR-influenced product requirements, while Russia maintains demand across hospital, regional, and public-sector diagnostic networks.

China is scaling domestic IVD manufacturing, hospital laboratory capacity, and NMPA-regulated diagnostic quality expectations; India is expanding diagnostics through public health programs and private laboratory networks; and Japan prioritizes precision, automation, quality assurance, and testing needs linked to an aging population. Australia maintains rigorous accreditation through NATA-linked systems and strong external quality assessment participation, while South Korea continues to grow through advanced diagnostics, export-oriented IVD manufacturing, digital health infrastructure, and technologically mature clinical laboratories.

Actionable Recommendations for IVD Quality Control Leaders

Industry leaders should prioritize commutable, matrix-appropriate, stable, and clinically relevant quality control materials that perform across multi-vendor testing platforms and diverse assay methodologies. Investment in lot-to-lot verification support, stability documentation, traceability, value assignment, uncertainty communication, and regulatory-ready technical files will improve competitiveness as laboratories demand higher confidence in QC performance.

Organizations should also build digital ecosystems around QC data, including peer comparison, middleware integration, automated rule monitoring, audit-ready reporting, and secure cloud-based analytics. Strategic partnerships with accredited laboratories, reference institutions, public health programs, and regional distributors can accelerate adoption, while training programs in ISO 15189, Westgard rules, risk-based quality management, and external quality assessment can strengthen customer retention and operational credibility.

Research Methodology for IVD Quality Control Analysis

This executive summary is based on a structured review of verified industry, regulatory, and clinical laboratory sources, including international laboratory standards, publicly available regulator guidance, accreditation frameworks, and established quality management practices in medical testing. The analysis considers product categories such as independent controls, calibrators, data management tools, proficiency testing, external quality assessment, and quality assurance services.

Regional and country insights were developed by evaluating regulatory maturity, healthcare infrastructure, diagnostic testing demand, laboratory accreditation adoption, public health investment, and adoption of automated and molecular diagnostic technologies. The methodology emphasizes data-backed interpretation, cross-source validation, and practical relevance for manufacturers, laboratories, distributors, healthcare providers, and investors operating in the IVD quality control ecosystem.

Conclusion: Quality Control as the Foundation of Reliable Diagnostics

In-vitro diagnostics quality control is becoming more strategic as laboratories face rising test complexity, stricter regulatory expectations, workforce constraints, and growing pressure to deliver accurate results at scale. The industry’s direction will be shaped by independent QC adoption, digital quality management, AI-supported monitoring, traceable materials, and broader use of proficiency testing and external quality assessment.

Organizations that combine scientifically robust QC materials with connected analytics, regulatory readiness, technical education, and regional expertise will be best positioned to grow responsibly. As diagnostic testing expands across centralized laboratories, decentralized care, public health networks, and point-of-care environments, quality control will remain essential to patient safety, clinical confidence, and sustainable IVD development.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. Market Size & Growth Trends
3.4. Market Share Analysis, 2025
3.5. FPNV Positioning Matrix, 2025
3.6. New Revenue Opportunities
3.7. Next-Generation Business Models
3.8. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Market Dynamics
4.3.1. Key Drivers
4.3.2. Key Restraints
4.3.3. Key Opportunities
4.3.4. Key Challenges
4.4. Porter’s Five Forces Analysis
4.5. PESTLE Analysis
4.6. Market Outlook
4.6.1. Near-Term Market Outlook (0-2 Years)
4.6.2. Medium-Term Market Outlook (3-5 Years)
4.6.3. Long-Term Market Outlook (5-10 Years)
4.7. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of Artificial Intelligence 2026
7. In-Vitro Diagnostics Quality Control Market, by Product Type
7.1. Analyzers & Instruments
7.1.1. Automated Systems
7.1.2. Semi-Automated Systems
7.2. Control Materials
7.3. QC Reagents
7.3.1. Liquid Controls
7.3.2. Lyophilized Controls
7.4. Software Solutions
7.4.1. Data Management Systems
7.4.2. LIMS
7.4.3. QC Software
8. In-Vitro Diagnostics Quality Control Market, by Technology
8.1. Clinical Chemistry
8.1.1. Colorimetric
8.1.2. Turbidimetric
8.2. Hematology
8.2.1. Automated Cell Counters
8.2.2. Flow Cytometry
8.3. Immunoassay
8.3.1. Chemiluminescence Immunoassay
8.3.2. ELISA
8.3.3. Fluorescence Immunoassay
8.4. Microbiology
8.4.1. Culture
8.4.2. PCR
8.5. Molecular Diagnostics
8.5.1. Next-Generation Sequencing
8.5.2. PCR
9. In-Vitro Diagnostics Quality Control Market, by Application
9.1. Cardiology
9.1.1. Cardiac Marker Testing
9.1.2. Point-Of-Care Testing
9.2. Genetic Testing
9.2.1. Carrier Screening
9.2.2. Prenatal Testing
9.3. Infectious Disease Testing
9.3.1. Bacterial Detection
9.3.2. Viral Detection
9.4. Oncology
9.4.1. Minimal Residual Disease
9.4.2. Tumor Marker Testing
9.5. Toxicology
9.5.1. Drugs Of Abuse
9.5.2. Therapeutic Drug Monitoring
10. In-Vitro Diagnostics Quality Control Market, by End User
10.1. Blood Banks
10.1.1. National Blood Banks
10.1.2. Regional Blood Banks
10.2. Diagnostic Laboratories
10.2.1. Hospital-Based Laboratories
10.2.2. Independent Laboratories
10.3. Hospitals & Clinics
10.3.1. Clinic Laboratories
10.3.2. Reference Laboratories
10.4. Research Institutes
10.4.1. Academic Institutes
10.4.2. Private Research Laboratories
11. Asia-Pacific In-Vitro Diagnostics Quality Control Market
12. North America In-Vitro Diagnostics Quality Control Market
13. Latin America In-Vitro Diagnostics Quality Control Market
14. Europe In-Vitro Diagnostics Quality Control Market
15. Middle East In-Vitro Diagnostics Quality Control Market
16. Africa In-Vitro Diagnostics Quality Control Market
17. ASEAN In-Vitro Diagnostics Quality Control Market
18. GCC In-Vitro Diagnostics Quality Control Market
19. European Union In-Vitro Diagnostics Quality Control Market
20. BRICS In-Vitro Diagnostics Quality Control Market
21. G7 In-Vitro Diagnostics Quality Control Market
22. NATO In-Vitro Diagnostics Quality Control Market
23. United States In-Vitro Diagnostics Quality Control Market
24. Canada In-Vitro Diagnostics Quality Control Market
25. Mexico In-Vitro Diagnostics Quality Control Market
26. Brazil In-Vitro Diagnostics Quality Control Market
27. United Kingdom In-Vitro Diagnostics Quality Control Market
28. Germany In-Vitro Diagnostics Quality Control Market
29. France In-Vitro Diagnostics Quality Control Market
30. Russia In-Vitro Diagnostics Quality Control Market
31. Italy In-Vitro Diagnostics Quality Control Market
32. Spain In-Vitro Diagnostics Quality Control Market
33. China In-Vitro Diagnostics Quality Control Market
34. India In-Vitro Diagnostics Quality Control Market
35. Japan In-Vitro Diagnostics Quality Control Market
36. Australia In-Vitro Diagnostics Quality Control Market
37. South Korea In-Vitro Diagnostics Quality Control Market
38. Competitive Landscape
38.1. Market Concentration Analysis, 2025
38.1.1. Concentration Ratio (CR)
38.1.2. Herfindahl Hirschman Index (HHI)
38.2. Recent Developments & Impact Analysis, 2025
38.3. Product Portfolio Analysis, 2025
38.4. Benchmarking Analysis, 2025
39. Company Profiles
39.1. Abbott Laboratories
39.2. AccuBioTech Co., Ltd.
39.3. Becton, Dickinson and Company
39.4. Bio-Rad Laboratories, Inc.
39.5. Bio-Techne Corporation
39.6. bioMérieux SA
39.7. BioSystems S.A.
39.8. Danaher Corporation
39.9. DiaSorin S.p.A.
39.10. EKF Diagnostics Holdings plc
39.11. F. Hoffmann-La Roche Ltd.
39.12. Fujirebio Holdings, Inc.
39.13. Helena Laboratories
39.14. Instand e.V.
39.15. LGC Limited
39.16. Maine Molecular Quality Controls, Inc.
39.17. Meridian Bioscience, Inc.
39.18. Microbiologics Inc.
39.19. Microbix Biosystems Inc.
39.20. Qnostics Ltd.
39.21. QuidelOrtho Corporation
39.22. Randox Laboratories Ltd.
39.23. Randox Toxicology
39.24. SEKISUI Diagnostics, LLC
39.25. SeraCare Life Sciences
39.26. Siemens Healthineers AG
39.27. Sun Diagnostics, LLC
39.28. Sysmex Corporation
39.29. Technopath Clinical Diagnostics
39.30. Thermo Fisher Scientific Inc.
List of Figures
FIGURE 1. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET, YEARS CONSIDERED FOR THE STUDY
FIGURE 2. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET, RESEARCH DESIGN
FIGURE 3. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET, RESEARCH FRAMEWORK
FIGURE 4. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET, DATA TRIANGULATION
FIGURE 5. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 6. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY REGION, 2025 VS 2032 (%)
FIGURE 7. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 8. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
FIGURE 9. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 10. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY COUNTRY, 2025 VS 2032 (%)
FIGURE 11. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 12. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SHARE, BY KEY PLAYER, 2025
FIGURE 13. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET, FPNV POSITIONING MATRIX, BY KEY PLAYER, 2025
FIGURE 14. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2032 (%)
FIGURE 15. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 16. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY TECHNOLOGY, 2025 VS 2032 (%)
FIGURE 17. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY TECHNOLOGY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 18. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY APPLICATION, 2025 VS 2032 (%)
FIGURE 19. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 20. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY END USER, 2025 VS 2032 (%)
FIGURE 21. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 22. ASIA-PACIFIC IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY REGION, 2025 VS 2032 (%)
FIGURE 23. ASIA-PACIFIC IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 24. NORTH AMERICA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY REGION, 2025 VS 2032 (%)
FIGURE 25. NORTH AMERICA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 26. LATIN AMERICA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY REGION, 2025 VS 2032 (%)
FIGURE 27. LATIN AMERICA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 28. EUROPE IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY REGION, 2025 VS 2032 (%)
FIGURE 29. EUROPE IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 30. MIDDLE EAST IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY REGION, 2025 VS 2032 (%)
FIGURE 31. MIDDLE EAST IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 32. AFRICA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY REGION, 2025 VS 2032 (%)
FIGURE 33. AFRICA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 34. ASEAN IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
FIGURE 35. ASEAN IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 36. GCC IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
FIGURE 37. GCC IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 38. EUROPEAN UNION IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
FIGURE 39. EUROPEAN UNION IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 40. BRICS IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
FIGURE 41. BRICS IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 42. G7 IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
FIGURE 43. G7 IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 44. NATO IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
FIGURE 45. NATO IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 46. UNITED STATES IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 47. CANADA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 48. MEXICO IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 49. BRAZIL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 50. UNITED KINGDOM IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 51. GERMANY IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 52. FRANCE IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 53. RUSSIA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 54. ITALY IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 55. SPAIN IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 56. CHINA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 57. INDIA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 58. JAPAN IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 59. AUSTRALIA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 60. SOUTH KOREA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, 2018-2032 (USD MILLION)
List of Tables
TABLE 1. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SEGMENTATION & COVERAGE
TABLE 2. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 3. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 4. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 5. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 6. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SHARE, BY KEY PLAYER, 2025
TABLE 7. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET, FPNV POSITIONING MATRIX, BY KEY PLAYER, 2025
TABLE 8. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 9. GLOBAL ANALYZERS & INSTRUMENTS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 10. GLOBAL ANALYZERS & INSTRUMENTS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 11. GLOBAL ANALYZERS & INSTRUMENTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 12. GLOBAL AUTOMATED SYSTEMS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 13. GLOBAL AUTOMATED SYSTEMS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 14. GLOBAL AUTOMATED SYSTEMS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 15. GLOBAL SEMI-AUTOMATED SYSTEMS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 16. GLOBAL SEMI-AUTOMATED SYSTEMS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 17. GLOBAL SEMI-AUTOMATED SYSTEMS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 18. GLOBAL CONTROL MATERIALS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 19. GLOBAL CONTROL MATERIALS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 20. GLOBAL CONTROL MATERIALS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 21. GLOBAL QC REAGENTS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 22. GLOBAL QC REAGENTS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 23. GLOBAL QC REAGENTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 24. GLOBAL LIQUID CONTROLS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 25. GLOBAL LIQUID CONTROLS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 26. GLOBAL LIQUID CONTROLS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 27. GLOBAL LYOPHILIZED CONTROLS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 28. GLOBAL LYOPHILIZED CONTROLS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 29. GLOBAL LYOPHILIZED CONTROLS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 30. GLOBAL SOFTWARE SOLUTIONS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 31. GLOBAL SOFTWARE SOLUTIONS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 32. GLOBAL SOFTWARE SOLUTIONS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 33. GLOBAL DATA MANAGEMENT SYSTEMS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 34. GLOBAL DATA MANAGEMENT SYSTEMS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 35. GLOBAL DATA MANAGEMENT SYSTEMS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 36. GLOBAL LIMS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 37. GLOBAL LIMS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 38. GLOBAL LIMS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 39. GLOBAL QC SOFTWARE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 40. GLOBAL QC SOFTWARE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 41. GLOBAL QC SOFTWARE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 42. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 43. GLOBAL CLINICAL CHEMISTRY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 44. GLOBAL CLINICAL CHEMISTRY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 45. GLOBAL CLINICAL CHEMISTRY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 46. GLOBAL COLORIMETRIC MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 47. GLOBAL COLORIMETRIC MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 48. GLOBAL COLORIMETRIC MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 49. GLOBAL TURBIDIMETRIC MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 50. GLOBAL TURBIDIMETRIC MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 51. GLOBAL TURBIDIMETRIC MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 52. GLOBAL HEMATOLOGY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 53. GLOBAL HEMATOLOGY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 54. GLOBAL HEMATOLOGY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 55. GLOBAL AUTOMATED CELL COUNTERS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 56. GLOBAL AUTOMATED CELL COUNTERS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 57. GLOBAL AUTOMATED CELL COUNTERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 58. GLOBAL FLOW CYTOMETRY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 59. GLOBAL FLOW CYTOMETRY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 60. GLOBAL FLOW CYTOMETRY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 61. GLOBAL IMMUNOASSAY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 62. GLOBAL IMMUNOASSAY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 63. GLOBAL IMMUNOASSAY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 64. GLOBAL CHEMILUMINESCENCE IMMUNOASSAY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 65. GLOBAL CHEMILUMINESCENCE IMMUNOASSAY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 66. GLOBAL CHEMILUMINESCENCE IMMUNOASSAY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 67. GLOBAL ELISA MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 68. GLOBAL ELISA MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 69. GLOBAL ELISA MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 70. GLOBAL FLUORESCENCE IMMUNOASSAY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 71. GLOBAL FLUORESCENCE IMMUNOASSAY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 72. GLOBAL FLUORESCENCE IMMUNOASSAY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 73. GLOBAL MICROBIOLOGY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 74. GLOBAL MICROBIOLOGY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 75. GLOBAL MICROBIOLOGY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 76. GLOBAL CULTURE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 77. GLOBAL CULTURE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 78. GLOBAL CULTURE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 79. GLOBAL PCR MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 80. GLOBAL PCR MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 81. GLOBAL PCR MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 82. GLOBAL MOLECULAR DIAGNOSTICS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 83. GLOBAL MOLECULAR DIAGNOSTICS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 84. GLOBAL MOLECULAR DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 85. GLOBAL NEXT-GENERATION SEQUENCING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 86. GLOBAL NEXT-GENERATION SEQUENCING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 87. GLOBAL NEXT-GENERATION SEQUENCING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 88. GLOBAL PCR MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 89. GLOBAL PCR MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 90. GLOBAL PCR MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 91. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 92. GLOBAL CARDIOLOGY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 93. GLOBAL CARDIOLOGY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 94. GLOBAL CARDIOLOGY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 95. GLOBAL CARDIAC MARKER TESTING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 96. GLOBAL CARDIAC MARKER TESTING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 97. GLOBAL CARDIAC MARKER TESTING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 98. GLOBAL POINT-OF-CARE TESTING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 99. GLOBAL POINT-OF-CARE TESTING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 100. GLOBAL POINT-OF-CARE TESTING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 101. GLOBAL GENETIC TESTING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 102. GLOBAL GENETIC TESTING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 103. GLOBAL GENETIC TESTING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 104. GLOBAL CARRIER SCREENING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 105. GLOBAL CARRIER SCREENING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 106. GLOBAL CARRIER SCREENING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 107. GLOBAL PRENATAL TESTING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 108. GLOBAL PRENATAL TESTING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 109. GLOBAL PRENATAL TESTING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 110. GLOBAL INFECTIOUS DISEASE TESTING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 111. GLOBAL INFECTIOUS DISEASE TESTING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 112. GLOBAL INFECTIOUS DISEASE TESTING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 113. GLOBAL BACTERIAL DETECTION MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 114. GLOBAL BACTERIAL DETECTION MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 115. GLOBAL BACTERIAL DETECTION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 116. GLOBAL VIRAL DETECTION MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 117. GLOBAL VIRAL DETECTION MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 118. GLOBAL VIRAL DETECTION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 119. GLOBAL ONCOLOGY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 120. GLOBAL ONCOLOGY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 121. GLOBAL ONCOLOGY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 122. GLOBAL MINIMAL RESIDUAL DISEASE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 123. GLOBAL MINIMAL RESIDUAL DISEASE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 124. GLOBAL MINIMAL RESIDUAL DISEASE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 125. GLOBAL TUMOR MARKER TESTING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 126. GLOBAL TUMOR MARKER TESTING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 127. GLOBAL TUMOR MARKER TESTING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 128. GLOBAL TOXICOLOGY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 129. GLOBAL TOXICOLOGY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 130. GLOBAL TOXICOLOGY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 131. GLOBAL DRUGS OF ABUSE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 132. GLOBAL DRUGS OF ABUSE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 133. GLOBAL DRUGS OF ABUSE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 134. GLOBAL THERAPEUTIC DRUG MONITORING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 135. GLOBAL THERAPEUTIC DRUG MONITORING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 136. GLOBAL THERAPEUTIC DRUG MONITORING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 137. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 138. GLOBAL BLOOD BANKS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 139. GLOBAL BLOOD BANKS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 140. GLOBAL BLOOD BANKS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 141. GLOBAL NATIONAL BLOOD BANKS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 142. GLOBAL NATIONAL BLOOD BANKS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 143. GLOBAL NATIONAL BLOOD BANKS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 144. GLOBAL REGIONAL BLOOD BANKS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 145. GLOBAL REGIONAL BLOOD BANKS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 146. GLOBAL REGIONAL BLOOD BANKS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 147. GLOBAL DIAGNOSTIC LABORATORIES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 148. GLOBAL DIAGNOSTIC LABORATORIES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 149. GLOBAL DIAGNOSTIC LABORATORIES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 150. GLOBAL HOSPITAL-BASED LABORATORIES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 151. GLOBAL HOSPITAL-BASED LABORATORIES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 152. GLOBAL HOSPITAL-BASED LABORATORIES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 153. GLOBAL INDEPENDENT LABORATORIES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 154. GLOBAL INDEPENDENT LABORATORIES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 155. GLOBAL INDEPENDENT LABORATORIES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 156. GLOBAL HOSPITALS & CLINICS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 157. GLOBAL HOSPITALS & CLINICS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 158. GLOBAL HOSPITALS & CLINICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 159. GLOBAL CLINIC LABORATORIES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 160. GLOBAL CLINIC LABORATORIES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 161. GLOBAL CLINIC LABORATORIES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 162. GLOBAL REFERENCE LABORATORIES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 163. GLOBAL REFERENCE LABORATORIES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 164. GLOBAL REFERENCE LABORATORIES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 165. GLOBAL RESEARCH INSTITUTES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 166. GLOBAL RESEARCH INSTITUTES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 167. GLOBAL RESEARCH INSTITUTES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 168. GLOBAL ACADEMIC INSTITUTES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 169. GLOBAL ACADEMIC INSTITUTES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 170. GLOBAL ACADEMIC INSTITUTES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 171. GLOBAL PRIVATE RESEARCH LABORATORIES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 172. GLOBAL PRIVATE RESEARCH LABORATORIES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 173. GLOBAL PRIVATE RESEARCH LABORATORIES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 174. ASIA-PACIFIC IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 175. ASIA-PACIFIC IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 176. ASIA-PACIFIC IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY ANALYZERS & INSTRUMENTS, 2018-2032 (USD MILLION)
TABLE 177. ASIA-PACIFIC IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY QC REAGENTS, 2018-2032 (USD MILLION)
TABLE 178. ASIA-PACIFIC IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY SOFTWARE SOLUTIONS, 2018-2032 (USD MILLION)
TABLE 179. ASIA-PACIFIC IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 180. ASIA-PACIFIC IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY CLINICAL CHEMISTRY, 2018-2032 (USD MILLION)
TABLE 181. ASIA-PACIFIC IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY HEMATOLOGY, 2018-2032 (USD MILLION)
TABLE 182. ASIA-PACIFIC IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY IMMUNOASSAY, 2018-2032 (USD MILLION)
TABLE 183. ASIA-PACIFIC IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY MICROBIOLOGY, 2018-2032 (USD MILLION)
TABLE 184. ASIA-PACIFIC IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2032 (USD MILLION)
TABLE 185. ASIA-PACIFIC IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 186. ASIA-PACIFIC IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY CARDIOLOGY, 2018-2032 (USD MILLION)
TABLE 187. ASIA-PACIFIC IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY GENETIC TESTING, 2018-2032 (USD MILLION)
TABLE 188. ASIA-PACIFIC IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY INFECTIOUS DISEASE TESTING, 2018-2032 (USD MILLION)
TABLE 189. ASIA-PACIFIC IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
TABLE 190. ASIA-PACIFIC IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY TOXICOLOGY, 2018-2032 (USD MILLION)
TABLE 191. ASIA-PACIFIC IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 192. ASIA-PACIFIC IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY BLOOD BANKS, 2018-2032 (USD MILLION)
TABLE 193. ASIA-PACIFIC IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2032 (USD MILLION)
TABLE 194. ASIA-PACIFIC IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY HOSPITALS & CLINICS, 2018-2032 (USD MILLION)
TABLE 195. ASIA-PACIFIC IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2032 (USD MILLION)
TABLE 196. NORTH AMERICA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 197. NORTH AMERICA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 198. NORTH AMERICA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY ANALYZERS & INSTRUMENTS, 2018-2032 (USD MILLION)
TABLE 199. NORTH AMERICA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY QC REAGENTS, 2018-2032 (USD MILLION)
TABLE 200. NORTH AMERICA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY SOFTWARE SOLUTIONS, 2018-2032 (USD MILLION)
TABLE 201. NORTH AMERICA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 202. NORTH AMERICA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY CLINICAL CHEMISTRY, 2018-2032 (USD MILLION)
TABLE 203. NORTH AMERICA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY HEMATOLOGY, 2018-2032 (USD MILLION)
TABLE 204. NORTH AMERICA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY IMMUNOASSAY, 2018-2032 (USD MILLION)
TABLE 205. NORTH AMERICA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY MICROBIOLOGY, 2018-2032 (USD MILLION)
TABLE 206. NORTH AMERICA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2032 (USD MILLION)
TABLE 207. NORTH AMERICA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 208. NORTH AMERICA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY CARDIOLOGY, 2018-2032 (USD MILLION)
TABLE 209. NORTH AMERICA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY GENETIC TESTING, 2018-2032 (USD MILLION)
TABLE 210. NORTH AMERICA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY INFECTIOUS DISEASE TESTING, 2018-2032 (USD MILLION)
TABLE 211. NORTH AMERICA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
TABLE 212. NORTH AMERICA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY TOXICOLOGY, 2018-2032 (USD MILLION)
TABLE 213. NORTH AMERICA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 214. NORTH AMERICA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY BLOOD BANKS, 2018-2032 (USD MILLION)
TABLE 215. NORTH AMERICA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2032 (USD MILLION)
TABLE 216. NORTH AMERICA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY HOSPITALS & CLINICS, 2018-2032 (USD MILLION)
TABLE 217. NORTH AMERICA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2032 (USD MILLION)
TABLE 218. LATIN AMERICA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 219. LATIN AMERICA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 220. LATIN AMERICA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY ANALYZERS & INSTRUMENTS, 2018-2032 (USD MILLION)
TABLE 221. LATIN AMERICA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY QC REAGENTS, 2018-2032 (USD MILLION)
TABLE 222. LATIN AMERICA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY SOFTWARE SOLUTIONS, 2018-2032 (USD MILLION)
TABLE 223. LATIN AMERICA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 224. LATIN AMERICA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY CLINICAL CHEMISTRY, 2018-2032 (USD MILLION)
TABLE 225. LATIN AMERICA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY HEMATOLOGY, 2018-2032 (USD MILLION)
TABLE 226. LATIN AMERICA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY IMMUNOASSAY, 2018-2032 (USD MILLION)
TABLE 227. LATIN AMERICA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY MICROBIOLOGY, 2018-2032 (USD MILLION)
TABLE 228. LATIN AMERICA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2032 (USD MILLION)
TABLE 229. LATIN AMERICA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 230. LATIN AMERICA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY CARDIOLOGY, 2018-2032 (USD MILLION)
TABLE 231. LATIN AMERICA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY GENETIC TESTING, 2018-2032 (USD MILLION)
TABLE 232. LATIN AMERICA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY INFECTIOUS DISEASE TESTING, 2018-2032 (USD MILLION)
TABLE 233. LATIN AMERICA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
TABLE 234. LATIN AMERICA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY TOXICOLOGY, 2018-2032 (USD MILLION)
TABLE 235. LATIN AMERICA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 236. LATIN AMERICA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY BLOOD BANKS, 2018-2032 (USD MILLION)
TABLE 237. LATIN AMERICA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2032 (USD MILLION)
TABLE 238. LATIN AMERICA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY HOSPITALS & CLINICS, 2018-2032 (USD MILLION)
TABLE 239. LATIN AMERICA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2032 (USD MILLION)
TABLE 240. EUROPE IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 241. EUROPE IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 242. EUROPE IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY ANALYZERS & INSTRUMENTS, 2018-2032 (USD MILLION)
TABLE 243. EUROPE IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY QC REAGENTS, 2018-2032 (USD MILLION)
TABLE 244. EUROPE IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY SOFTWARE SOLUTIONS, 2018-2032 (USD MILLION)
TABLE 245. EUROPE IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 246. EUROPE IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY CLINICAL CHEMISTRY, 2018-2032 (USD MILLION)
TABLE 247. EUROPE IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY HEMATOLOGY, 2018-2032 (USD MILLION)
TABLE 248. EUROPE IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY IMMUNOASSAY, 2018-2032 (USD MILLION)
TABLE 249. EUROPE IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY MICROBIOLOGY, 2018-2032 (USD MILLION)
TABLE 250. EUROPE IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2032 (USD MILLION)
TABLE 251. EUROPE IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 252. EUROPE IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY CARDIOLOGY, 2018-2032 (USD MILLION)
TABLE 253. EUROPE IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY GENETIC TESTING, 2018-2032 (USD MILLION)
TABLE 254. EUROPE IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY INFECTIOUS DISEASE TESTING, 2018-2032 (USD MILLION)
TABLE 255. EUROPE IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
TABLE 256. EUROPE IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY TOXICOLOGY, 2018-2032 (USD MILLION)
TABLE 257. EUROPE IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 258. EUROPE IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY BLOOD BANKS, 2018-2032 (USD MILLION)
TABLE 259. EUROPE IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2032 (USD MILLION)
TABLE 260. EUROPE IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY HOSPITALS & CLINICS, 2018-2032 (USD MILLION)
TABLE 261. EUROPE IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2032 (USD MILLION)
TABLE 262. MIDDLE EAST IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 263. MIDDLE EAST IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 264. MIDDLE EAST IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY ANALYZERS & INSTRUMENTS, 2018-2032 (USD MILLION)
TABLE 265. MIDDLE EAST IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY QC REAGENTS, 2018-2032 (USD MILLION)
TABLE 266. MIDDLE EAST IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY SOFTWARE SOLUTIONS, 2018-2032 (USD MILLION)
TABLE 267. MIDDLE EAST IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 268. MIDDLE EAST IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY CLINICAL CHEMISTRY, 2018-2032 (USD MILLION)
TABLE 269. MIDDLE EAST IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY HEMATOLOGY, 2018-2032 (USD MILLION)
TABLE 270. MIDDLE EAST IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY IMMUNOASSAY, 2018-2032 (USD MILLION)
TABLE 271. MIDDLE EAST IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY MICROBIOLOGY, 2018-2032 (USD MILLION)
TABLE 272. MIDDLE EAST IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2032 (USD MILLION)
TABLE 273. MIDDLE EAST IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 274. MIDDLE EAST IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY CARDIOLOGY, 2018-2032 (USD MILLION)
TABLE 275. MIDDLE EAST IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY GENETIC TESTING, 2018-2032 (USD MILLION)
TABLE 276. MIDDLE EAST IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY INFECTIOUS DISEASE TESTING, 2018-2032 (USD MILLION)
TABLE 277. MIDDLE EAST IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
TABLE 278. MIDDLE EAST IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY TOXICOLOGY, 2018-2032 (USD MILLION)
TABLE 279. MIDDLE EAST IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 280. MIDDLE EAST IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY BLOOD BANKS, 2018-2032 (USD MILLION)
TABLE 281. MIDDLE EAST IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2032 (USD MILLION)
TABLE 282. MIDDLE EAST IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY HOSPITALS & CLINICS, 2018-2032 (USD MILLION)
TABLE 283. MIDDLE EAST IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2032 (USD MILLION)
TABLE 284. AFRICA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 285. AFRICA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 286. AFRICA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY ANALYZERS & INSTRUMENTS, 2018-2032 (USD MILLION)
TABLE 287. AFRICA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY QC REAGENTS, 2018-2032 (USD MILLION)
TABLE 288. AFRICA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY SOFTWARE SOLUTIONS, 2018-2032 (USD MILLION)
TABLE 289. AFRICA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 290. AFRICA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY CLINICAL CHEMISTRY, 2018-2032 (USD MILLION)
TABLE 291. AFRICA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY HEMATOLOGY, 2018-2032 (USD MILLION)
TABLE 292. AFRICA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY IMMUNOASSAY, 2018-2032 (USD MILLION)
TABLE 293. AFRICA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY MICROBIOLOGY, 2018-2032 (USD MILLION)
TABLE 294. AFRICA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2032 (USD MILLION)
TABLE 295. AFRICA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 296. AFRICA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY CARDIOLOGY, 2018-2032 (USD MILLION)
TABLE 297. AFRICA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY GENETIC TESTING, 2018-2032 (USD MILLION)
TABLE 298. AFRICA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY INFECTIOUS DISEASE TESTING, 2018-2032 (USD MILLION)
TABLE 299. AFRICA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
TABLE 300. AFRICA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY TOXICOLOGY, 2018-2032 (USD MILLION)
TABLE 301. AFRICA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 302. AFRICA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY BLOOD BANKS, 2018-2032 (USD MILLION)
TABLE 303. AFRICA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2032 (USD MILLION)
TABLE 304. AFRICA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY HOSPITALS & CLINICS, 2018-2032 (USD MILLION)
TABLE 305. AFRICA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2032 (USD MILLION)
TABLE 306. ASEAN IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 307. ASEAN IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 308. ASEAN IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY ANALYZERS & INSTRUMENTS, 2018-2032 (USD MILLION)
TABLE 309. ASEAN IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY QC REAGENTS, 2018-2032 (USD MILLION)
TABLE 310. ASEAN IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY SOFTWARE SOLUTIONS, 2018-2032 (USD MILLION)
TABLE 311. ASEAN IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 312. ASEAN IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY CLINICAL CHEMISTRY, 2018-2032 (USD MILLION)
TABLE 313. ASEAN IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY HEMATOLOGY, 2018-2032 (USD MILLION)
TABLE 314. ASEAN IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY IMMUNOASSAY, 2018-2032 (USD MILLION)
TABLE 315. ASEAN IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY MICROBIOLOGY, 2018-2032 (USD MILLION)
TABLE 316. ASEAN IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2032 (USD MILLION)
TABLE 317. ASEAN IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 318. ASEAN IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY CARDIOLOGY, 2018-2032 (USD MILLION)
TABLE 319. ASEAN IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY GENETIC TESTING, 2018-2032 (USD MILLION)
TABLE 320. ASEAN IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY INFECTIOUS DISEASE TESTING, 2018-2032 (USD MILLION)
TABLE 321. ASEAN IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
TABLE 322. ASEAN IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY TOXICOLOGY, 2018-2032 (USD MILLION)
TABLE 323. ASEAN IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 324. ASEAN IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY BLOOD BANKS, 2018-2032 (USD MILLION)
TABLE 325. ASEAN IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2032 (USD MILLION)
TABLE 326. ASEAN IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY HOSPITALS & CLINICS, 2018-2032 (USD MILLION)
TABLE 327. ASEAN IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2032 (USD MILLION)
TABLE 328. GCC IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 329. GCC IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 330. GCC IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY ANALYZERS & INSTRUMENTS, 2018-2032 (USD MILLION)
TABLE 331. GCC IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY QC REAGENTS, 2018-2032 (USD MILLION)
TABLE 332. GCC IN-VITRO DIAGNOSTICS QUALITY CO

Companies Mentioned

The companies featured in this In-Vitro Diagnostics Quality Control market report include:
  • Abbott Laboratories
  • AccuBioTech Co., Ltd.
  • Becton, Dickinson and Company
  • Bio-Rad Laboratories, Inc.
  • Bio-Techne Corporation
  • bioMérieux SA
  • BioSystems S.A.
  • Danaher Corporation
  • DiaSorin S.p.A.
  • EKF Diagnostics Holdings plc
  • F. Hoffmann-La Roche Ltd.
  • Fujirebio Holdings, Inc.
  • Helena Laboratories
  • Instand e.V.
  • LGC Limited
  • Maine Molecular Quality Controls, Inc.
  • Meridian Bioscience, Inc.
  • Microbiologics Inc.
  • Microbix Biosystems Inc.
  • Qnostics Ltd.
  • QuidelOrtho Corporation
  • Randox Laboratories Ltd.
  • Randox Toxicology
  • SEKISUI Diagnostics, LLC
  • SeraCare Life Sciences
  • Siemens Healthineers AG
  • Sun Diagnostics, LLC
  • Sysmex Corporation
  • Technopath Clinical Diagnostics
  • Thermo Fisher Scientific Inc.

Table Information

Report AttributeDetails
No. of Pages198
PublishedJune 2026
Forecast Period2026 - 2032
Estimated Market Value ( USD ) in 2026 $ 1.74 Billion
Forecasted Market Value ( USD ) by 2032 $ 2.88 Billion
Compound Annual Growth Rate8.6%
Regions CoveredGlobal
No. of Companies Mentioned31

Related Topics

Related Reports

In-Vitro Diagnostics Quality Control - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2026-2031) - Product Image

In-Vitro Diagnostics Quality Control - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2026-2031)

  • Report
  • 110 Pages
  • Global
From
In Vitro Diagnostics Quality Control Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2021-2031F - Product Image

In Vitro Diagnostics Quality Control Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2021-2031F

  • Report
  • 180 Pages
  • Global
From
In Vitro Diagnostics Quality Control Market by Product & Service, Technology, Manufacturer, End User, and Region - Global Forecast to 2030 - Product Image

In Vitro Diagnostics Quality Control Market by Product & Service, Technology, Manufacturer, End User, and Region - Global Forecast to 2030

  • Report
  • 379 Pages
  • Global
From
In Vitro Diagnostic Quality Control Market: Strategy & Trends with Forecasts by Assay Type, by Place, by Product, by Manufacturer and by Country - Situation Analysis with Executive & Consultant Guides - Product Image

In Vitro Diagnostic Quality Control Market: Strategy & Trends with Forecasts by Assay Type, by Place, by Product, by Manufacturer and by Country - Situation Analysis with Executive & Consultant Guides

  • Report
  • 372 Pages
  • Global
From
Infectious Diseases In-Vitro Diagnostics Market by Product, Technology, Pathogen, Application, End User - Global Forecast 2026-2032 - Product Image

Infectious Diseases In-Vitro Diagnostics Market by Product, Technology, Pathogen, Application, End User - Global Forecast 2026-2032

  • Report
  • 193 Pages
  • Global
From
Copyright © 2002-2026 Research and Markets. All Rights Reserved.